Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
SANA on Nasdaq
Shares outstanding
266,434,249
Price per share
$4.07
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
163,623,611
Total reported value
$580,877,242
% of total 13F portfolios
0%
Share change
+18,161,386
Value change
+$66,215,019
Number of holders
177
Price from insider filings
$4.07
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund IX, L.P. 17% $163,630,594 46,093,125 Robert Nelsen 30 Sep 2025
BlackRock, Inc. 4.9% $19,407,853 11,027,189 BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 4.8% $18,916,058 10,747,760 The Vanguard Group 31 Dec 2024

As of 30 Sep 2025, 177 institutional investors reported holding 163,623,611 shares of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA). This represents 61% of the company’s total 266,434,249 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 14% 37,431,365 +11% 0.01% $132,881,346
Flagship Pioneering Inc. 9.4% 25,001,856 0% 30% $88,756,589
BAILLIE GIFFORD & CO 4.3% 11,436,503 +14% 0.03% $40,599,586
BlackRock, Inc. 4.2% 11,226,136 +3.4% 0% $39,852,782
CANADA PENSION PLAN INVESTMENT BOARD 3.8% 10,175,000 0% 0.03% $36,121,250
VANGUARD GROUP INC 3.4% 9,128,973 +20% 0% $32,407,854
STATE STREET CORP 2.5% 6,680,541 +134% 0% $23,715,921
CITADEL ADVISORS LLC 2.5% 6,551,977 +122% 0.02% $23,259,519
Marex Group plc 1.4% 3,822,780 +0.13% 0.17% $13,570,869
GEODE CAPITAL MANAGEMENT, LLC 1.3% 3,423,532 +4.4% 0% $12,155,856
Alphabet Inc. 1.1% 2,812,500 0% 0.41% $9,984,375
JPMORGAN CHASE & CO 0.8% 2,135,444 +181% 0% $7,580,826
BAKER BROS. ADVISORS LP 0.76% 2,030,949 0% 0.05% $7,209,869
Integral Health Asset Management, LLC 0.75% 2,000,000 +33% 0.52% $7,100,000
RENAISSANCE TECHNOLOGIES LLC 0.75% 1,992,500 +878% 0.01% $7,073,375
Crestline Management, LP 0.68% 1,820,937 -25% 11% $6,464,326
MILLENNIUM MANAGEMENT LLC 0.61% 1,620,000 +103% 0% $5,751,000
UBS Group AG 0.54% 1,443,986 +26% 0% $5,126,150
Woodline Partners LP 0.52% 1,378,236 +76% 0.02% $4,892,738
NORTHERN TRUST CORP 0.49% 1,318,496 +14% 0% $4,680,661
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.48% 1,272,563 +17% 0% $4,517,599
AQR CAPITAL MANAGEMENT LLC 0.44% 1,181,782 -13% 0% $4,195,328
BANK OF AMERICA CORP /DE/ 0.34% 917,642 +3.7% 0% $3,257,628
MORGAN STANLEY 0.33% 876,505 -41% 0% $3,111,593
Omega Fund Management, LLC 0.32% 843,750 0% 1.3% $2,995,313

Institutional Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 164,505 $686,147 +$37,469 $4.07 5
2025 Q3 163,623,611 $580,877,242 +$66,215,019 $3.55 177
2025 Q2 145,529,650 $398,240,759 -$12,602,312 $2.73 153
2025 Q1 149,116,670 $250,511,096 -$14,520,097 $1.68 156
2024 Q4 157,927,058 $257,416,034 -$1,264,160 $1.63 158
2024 Q3 153,070,144 $636,844,420 +$15,469,267 $4.16 154
2024 Q2 148,181,280 $809,095,908 -$349,502 $5.46 149
2024 Q1 5,838,884 $58,387,367 +$5,986,757 $10.00 13
2023 Q4 78,220 $329,938 -$46,868 $4.22 2
2023 Q3 127,224,368 $492,369,952 -$30,210,236 $3.87 130
2023 Q2 134,614,817 $802,298,695 +$25,709,331 $5.96 119
2023 Q1 130,459,977 $426,581,510 +$6,801,018 $3.27 116
2022 Q4 128,317,982 $506,822,179 +$988,224 $3.95 116
2022 Q3 127,456,132 $764,600,931 +$15,334,212 $6.00 115
2022 Q2 124,575,071 $800,976,039 +$45,788,573 $6.43 106
2022 Q1 117,559,300 $970,495,531 +$27,758,718 $8.26 105
2021 Q4 110,407,255 $1,709,226,718 +$21,638,668 $15.48 97
2021 Q3 109,950,783 $2,477,138,522 +$266,078,026 $22.52 88
2021 Q2 64,059,271 $1,259,280,145 +$104,914,085 $19.66 77
2021 Q1 58,277,853 $1,950,554,711 +$1,950,554,479 $33.47 75